In September 2025, the FDA issued a warning letter addressed to Hims & Hers leadership after reviewing the forhers.com website and identifying compounded semaglutide claims it called false or misleading, including language asserting a weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy and clinically proven ingredients. Now look at the February 2026 weight-loss pill announcement: it describes a compounded semaglutide pill with the same active ingredient as Wegovy. Separately, the FDAs February 2026 enforcement statement again called out the same active ingredient and clinically proven claim types as lines companies cannot cross in promotional materials
Schmitt, B., Vicenzi, M., Garrel, C., & Denis, F
Wear soft, breathable clothing and consider over-the-counter hydrocortisone cream (1%) for localized itching
Danni Rowlands, the director of education initiatives at eating disorder charity the Butterfly Foundation, said commentary around weight loss had changed over the decades
Yet, they attribute any improvements to the peptide rather than to the constellation of changes they made and the natural healing that would have likely occurred anyway
